Biotech Going Generic Like Big Pharma? [View article]
Mike Havrilla:
The problem with anything in the health industry is that the new president has implied that he doesn't think companies in the sector should be for profit companies.
If he follows through on his beliefs, as he so far has, nothing will matter in the industry.
Wall Street Breakfast: Must-Know News [View article]
As always, thank you for your reporting. Nice to have it all together.
Keep it up, please. AD
Companies' Cash Holdings: The Winners and Losers [View article]
There are a few claw marks on the wall at the bottom of the hole we're in, but we're not out of this one yet.
Thus, companies that still have positive real earnings and plenty of cash are better able to survive and potentially thrive.
Thanks for the heavy-on-cash report.
Biotech Going Generic Like Big Pharma? [View article]
The problem with anything in the health industry is that the new president has implied that he doesn't think companies in the sector should be for profit companies.
If he follows through on his beliefs, as he so far has, nothing will matter in the industry.